Literature DB >> 179836

An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.

E X Albuquerque, J E Rash, R F Mayer, J R Satterfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 179836     DOI： 10.1016/0014-4886(76)90179-5

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  23 in total

Review 1.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

Review 2.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Myasthenic serum selectively blocks acetylcholine receptors with long channel open times at developing rat endplates.

Authors:  S M Schuetze; S Vicini; Z W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.

Authors:  K V Toyka; K L Birnberger; A P Anzil; C Schlegel; U Besinger; A Struppler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-08       Impact factor: 10.154

5.  On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates.

Authors:  S G Cull-Candy; R Miledi; A Trautmann; O D Uchitel
Journal:  J Physiol       Date:  1980-02       Impact factor: 5.182

6.  Pathophysiological studies of neuromuscular function in subacute organophosphate poisoning induced by phosmet.

Authors:  J L Good; R K Khurana; R F Mayer; W M Cintra; E X Albuquerque
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

7.  Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.

Authors:  K V Toyka; B Löwenadler; K Heininger; U A Besinger; K L Birnberger; A Fateh-Moghadam; E Heilbronn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-09       Impact factor: 10.154

8.  Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.

Authors:  D B Sanders; Y I Kim; J F Howard; C A Goetsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

9.  Clinical electrophysiology in myasthenia gravis.

Authors:  E Stalberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

10.  Subpopulations of T lymphocytes in myasthenia gravis patients.

Authors:  M Piantelli; L Lauriola; A Carbone; A Evoli; P Tonali; P Musiani
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.